Lazada Urged to Remove Unregistered E-Cigarettes in Philippines

Mar.16.2023
Lazada Urged to Remove Unregistered E-Cigarettes in Philippines
Lazada urged to remove unregistered e-cigarettes from its platform, similar to Shopee, in compliance with Philippine e-cigarette regulations.

The Philippine E-Cigarette Industry Association (PECIA) and the Philippine Nicotine Consumers Union (NCUP) are urging Lazada to follow in the footsteps of Shopee and remove unregistered e-cigarette products in compliance with the country's Vaporized Nicotine and Non-Nicotine Products Regulation Act (RA 11900), which will take effect on July 25, 2022.


The bill covers electronic cigarette products, e-cigarette juices, e-cigarette devices, heated tobacco products, HTP consumables and devices, and new tobacco products. With the IRR set to take effect on December 28, 2022, all prohibited items under RA 11900 will no longer be sold in online and offline retail markets.


Joey Dulay, the president of PECIA, has stated that Lazada, being one of the most popular online markets, should ensure consumer welfare and protect them from unregistered and substandard products that may cause harm.


The Ministry of Industry has stated unequivocally that Lazada is responsible for complying with e-cigarette-related legislation. Shopee is a platform similar in size to Lazada, and has taken down more than one million unregistered e-cigarette listings from its website. Lazada should also take this issue seriously.


In January of this year, NCUP wrote separate letters to Shopee and Lazada, commending Shopee for taking swift and decisive action against illegal electronic cigarette products, and strongly encouraging Lazada to follow the example set by its competitor.


These platforms have a huge influence on consumers. If they see it on websites, they will think it is safe. Lazada plays a crucial role in preventing the consumption of illegal products. There are now appropriate laws to regulate electronic cigarettes, but if the platform itself does not comply, the law cannot be enforced," said NCUP President Anton Israel in the letter.


On March 1st, representatives from electronic commerce platforms met with the Department of Trade and Industry (DTI) through the Consumer Protection Group (CPG) to address the issue of banned nicotine and non-nicotine vaping products being advertised and sold online despite ongoing monitoring and law enforcement efforts.


On March 1, 2022, the Department of Trade and Industry (DTI) of the Philippines held a meeting with representatives from e-commerce platforms through the Consumer Protection Group (CPG) to address the issue of prohibiting the sale of illegal e-cigarettes online.


One day after the dialogue, Shopee reported that it had removed over one million illegal listings of electronic cigarettes from its platform. It also pledged to strengthen its monitoring of illegal electronic cigarette products and commit to continued cooperation with the trade organization.


Under RA 11900, only electronic cigarette products, devices, and new tobacco products that are registered and certified by the Philippines' Bureau of Standards (BPS) and accompanied by appropriate health warnings can be sold to the public by June 2024.


PECIA is the largest trade organization for electronic cigarettes in the Philippines, with over 200 member shop owners, suppliers, and manufacturers, as well as more than 8,000 E-cigarette alliances, representing over one million smokeless product consumers in the Philippines.


NCUP is a non-profit national advocacy organization that believes the rights and interests of millions of smokers and electronic cigarette users in the Philippines need to be protected from the influence of untested, unregulated, and unregistered products.


Reference:


Lazada has been requested to take down illegal vaping products from its online marketplace.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
U.S. Fifth Circuit Vacates NicQuid Vape MDO, Says FDA Comparative-Efficacy Standard Violated APA Procedures
According to VitalLaw on August 27, 2026, the U.S. Court of Appeals for the Fifth Circuit vacated an FDA marketing denial order (MDO) against NicQuid LLC, ruling that the agency’s comparative-efficacy standard for electronic nicotine delivery system (ENDS) applications had become a substantive rule requiring notice-and-comment rulemaking under the Administrative Procedure Act (APA). The court did not reject FDA’s authority to compare the public health benefits and risks of flavored vapes, but held that the agency could not establish a broadly binding standard through informal adjudications. The case was remanded to FDA for further proceedings.
Aug.28
China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang files patent for pressure-triggered, on-demand oral nicotine release
China Tobacco Zhejiang Industrial Co., Ltd. has filed a patent application for an oral nicotine delivery product designed to let users actively adjust nicotine release. The product embeds two types of nicotine reservoirs with different wall thicknesses and positions inside a deformable matrix. Pressure applied with the tongue or lips can rupture the reservoirs and accelerate nicotine release. In simulated oral tests, several patent examples showed sharply higher peak nicotine release rates as applied force increased from 0 N to 1 N and 3 N. The filing explores a shift from preset release profiles toward user-triggered nicotine delivery.
Sep.01
Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
U.S. President Donald Trump has named Pastor Darrell Scott to serve as an adviser on tobacco health issues on the Centers for Disease Control and Prevention’s Advisory Committee to the Director. Trump said Scott would focus on the burden of tobacco-related disease and help examine ways to protect Americans from dangerous tobacco products while supporting solutions that reduce harm. Scott’s public career has largely centered on faith leadership, community advocacy and politics.
Sep.02
 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus Enters Japan’s FamilyMart Network With Zero-Nicotine NEO Line and Kishidan Campaign
Snowplus distributor H&S said the zero-nicotine, zero-tar NEO vaping line will begin rolling out across FamilyMart stores in Japan from September 14, 2026, excluding some locations. The DASH line will also be sold at selected FamilyMart stores in southern Kyushu and Okinawa. Snowplus simultaneously named Japanese rock band Kishidan as a brand ambassador, combining convenience-store distribution with a broader consumer marketing push in Japan.
Sep.15
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19